BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22636784)

  • 1. Expanded roles for multicargo and class 1B effector chaperones in type III secretion.
    Thomas NA; Ma I; Prasad ME; Rafuse C
    J Bacteriol; 2012 Aug; 194(15):3767-73. PubMed ID: 22636784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel T3SS effector EseK in Edwardsiella piscicida is chaperoned by EscH and EscS to express virulence.
    Cao H; Yang C; Quan S; Hu T; Zhang L; Zhang Y; Yang D; Liu Q
    Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 29024267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new means to identify type 3 secreted effectors: functionally interchangeable class IB chaperones recognize a conserved sequence.
    Costa SC; Schmitz AM; Jahufar FF; Boyd JD; Cho MY; Glicksman MA; Lesser CF
    mBio; 2012; 3(1):. PubMed ID: 22334517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
    Dai W; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coli.
    Thomassin JL; He X; Thomas NA
    BMC Microbiol; 2011 Sep; 11():205. PubMed ID: 21933418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway.
    Ernst NH; Reeves AZ; Ramseyer JE; Lesser CF
    mBio; 2018 Jun; 9(3):. PubMed ID: 29921672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of a chaperone-bound type III secretion substrate with the export gate.
    Gilzer D; Schreiner M; Niemann HH
    Nat Commun; 2022 Jun; 13(1):2858. PubMed ID: 35654781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel C-terminal region within the multicargo type III secretion chaperone CesT contributes to effector secretion.
    Ramu T; Prasad ME; Connors E; Mishra A; Thomassin JL; Leblanc J; Rainey JK; Thomas NA
    J Bacteriol; 2013 Feb; 195(4):740-56. PubMed ID: 23222727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperone-mediated secretion switching from early to middle substrates in the type III secretion system encoded by
    Takaya A; Takeda H; Tashiro S; Kawashima H; Yamamoto T
    J Biol Chem; 2019 Mar; 294(10):3783-3793. PubMed ID: 30651351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CesT is a multi-effector chaperone and recruitment factor required for the efficient type III secretion of both LEE- and non-LEE-encoded effectors of enteropathogenic Escherichia coli.
    Thomas NA; Deng W; Puente JL; Frey EA; Yip CK; Strynadka NC; Finlay BB
    Mol Microbiol; 2005 Sep; 57(6):1762-79. PubMed ID: 16135239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.
    Brinkworth AJ; Malcolm DS; Pedrosa AT; Roguska K; Shahbazian S; Graham JE; Hayward RD; Carabeo RA
    Mol Microbiol; 2011 Oct; 82(1):131-44. PubMed ID: 21883523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the docking site between a type III secretion system ATPase and a chaperone for effector cargo.
    Allison SE; Tuinema BR; Everson ES; Sugiman-Marangos S; Zhang K; Junop MS; Coombes BK
    J Biol Chem; 2014 Aug; 289(34):23734-44. PubMed ID: 25035427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Salmonella type three secretion effector/chaperone complex adopts a hexameric ring-like structure.
    Roblin P; Dewitte F; Villeret V; Biondi EG; Bompard C
    J Bacteriol; 2015 Feb; 197(4):688-98. PubMed ID: 25404693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia.
    Davis AJ; Díaz DA; Mecsas J
    Mol Microbiol; 2010 Apr; 76(1):236-59. PubMed ID: 20199604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional dissection of translocon proteins of the Salmonella pathogenicity island 2-encoded type III secretion system.
    Hölzer SU; Hensel M
    BMC Microbiol; 2010 Apr; 10():104. PubMed ID: 20377892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New players in the same old game: a system level in silico study to predict type III secretion system and effector proteins in bacterial genomes reveals common themes in T3SS mediated pathogenesis.
    Sadarangani V; Datta S; Arunachalam M
    BMC Res Notes; 2013 Jul; 6():297. PubMed ID: 23890184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional domains and motifs of bacterial type III effector proteins and their roles in infection.
    Dean P
    FEMS Microbiol Rev; 2011 Nov; 35(6):1100-25. PubMed ID: 21517912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of VPA0451 as the specific chaperone for the Vibrio parahaemolyticus chromosome 1 type III-secreted effector VPA0450.
    Waddell B; Southward CM; McKenna N; Devinney R
    FEMS Microbiol Lett; 2014 Apr; 353(2):141-50. PubMed ID: 24606036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological Analysis of the Type 3 Secretion System Translocon Pore Protein IpaC following Its Native Delivery to the Plasma Membrane during Infection.
    Russo BC; Duncan JK; Goldberg MB
    mBio; 2019 May; 10(3):. PubMed ID: 31138750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.